Nanotemplate Engineering of Cell Specific Nanoparticles

References

• Douglas , S. J. , Davis , S. S. and Illum , L. 1987 . Nanoparticles in drug delivery . Crit. Rev. Ther. Drug Carrier. Syst. , 3 : 233 – 261 .
   PubMed Web of Science ®Google Scholar
• Kreuter , J. 1995 . Nanoparticles as adjuvants for vaccines . Pharm. Biotechnol. , 6 : 463 – 472 .
   PubMedGoogle Scholar
• MacLaughlin , F. C. , Mumper , R. J. , Wang , J. , Tagliaferri , J. M. and Rolland , A. P. 1998 . Chitosan and depolymerized chitosan oligomers as condensing carriers for in‐vivo plasmid delivery . J. Controlled Rel. , 56 : 259 – 272 .
   PubMed Web of Science ®Google Scholar
• Mumper , R. J. and Ledebur , H. C. 2001 . Dendritic cell delivery of plasmid DNA: applications for genetic vaccines . Mol. Biotech. , 19 ( 1 ) : 79 – 95 .
   PubMed Web of Science ®Google Scholar
• Mumper , R. J. and Klakamp , S. L. 1999 . “ Polymeric gene delivery systems for in‐vivo gene therapy ” . In Advanced Gene Delivery: From Concepts to Pharmaceutical Products Edited by: Rolland , A. P. 143 – 173 . Amsterdam , , The Netherlands : Harwood Academic Publishers .
   Google Scholar
• Tang , D. C. , DeVit , M. and Johnston , S. A. 1992 . Genetic immunization is a simple method for eliciting an immune response . Nature , 356 : 152 – 154 .
   PubMed Web of Science ®Google Scholar
• Ulmer , J. B. , Sadoff , J. C. and Liu , M. A. 1996 . DNA vaccines . Cur. Opin. Immunol. , 8 : 531 – 536 .
   PubMed Web of Science ®Google Scholar
• Liu , M. A. , Hilleman , M. R. and Kurth , R. 1995 . DNA vaccines: a new era in vaccinology . Ann. NY Acad. Sci. , 772
   Web of Science ®Google Scholar
• Robinson , H. L. and Torres , C. A.T. 1997 . DNA vaccines . Sem. Immunology , 9 : 271 – 283 .
   PubMedGoogle Scholar
• Lattes , A. and Rico‐Lattes , I. 1994 . Microemulsions of perfluorinated and semi‐fluorinated compounds . Art. Cells. Blood Subs. Immob. Biotech. , 22 : 1007 – 1018 .
   PubMed Web of Science ®Google Scholar
• Riess , J. G. and Krafft , M. P. 1997 . Advanced fluorocarbon‐based systems for oxygen and drug delivery, and diagnosis . Art. Cells. Blood Subs. Immob. Biotech. , 25 : 43 – 52 .
   PubMed Web of Science ®Google Scholar
• Constantinides , P. P. 1995 . Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects . Pharm. Res. , 12 : 1561 – 1572 .
   PubMed Web of Science ®Google Scholar
• Bhargava , H. N. , Narurkar , A. and Lieb , L. M. 1987 . Using microemulsions for drug delivery . Pharm. Tech. , March : 46 – 53 .
   Google Scholar
• Ho , H. O. , Hsiao , C. C. and Sheu , M. T. 1996 . Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs . J. Pharm. Sci. , 85 : 138 – 143 .
   PubMed Web of Science ®Google Scholar
• Li , Y. and Park , C. W. 1999 . Particle size distribution in the synthesis of nanoparticles using microemulsions . Langmuir , 15 : 952 – 956 .
   Web of Science ®Google Scholar
• Cavalli , R. , Peira , E. , Caputo , O. and Gasco , M. R. 1999 . Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with cyclodextrins . Int. J. Pharm. , 182 : 59 – 69 .
   PubMed Web of Science ®Google Scholar
• Bocca , C. , Caputo , O. , Cavalli , R. , Gabriel , L. , Miglietta , A. and Gasco , M. R. 1998 . Phagocytic uptake of fluorescent stealth and non‐stealth solid lipid nanoparticles . Int. J. Pharm. , 175 : 185 – 193 .
   Web of Science ®Google Scholar
• Tojo , C. , Blanco , M. C. and Lopez‐Quintela , M. A. 1998 . Influence of reactant excess and film flexibility on the mechanism of nanoparticle formation in microemulsions: a Monte Carlo simulation . Langmuir , 14 : 6835 – 6839 .
   Web of Science ®Google Scholar
• Munshi , N. , De , T. K. and Maitra , A. 1997 . Preparation and size modulation of drug loaded nanoencapsulated particles using microemulsion mediated method . J. Control. Release , 41 : S7
   Google Scholar
• Ruys , A. J. and Mai , Y. W. 1999 . The nanoparticle‐coating process: a potential sol‐gel route to homogeneous nanocomposites . Mater. Sci. Eng. , 265 : 202 – 207 .
   Google Scholar
• Lade , M. , Mays , H. , Schmidt , J. , Willumeit , R. and Schomäcker , R. 2000 . On the nanoparticle synthesis in microemulsions: detailed characterization of an applied reaction mixture . Colloid. Surface. A , 163 : 3 – 15 .
   Web of Science ®Google Scholar
• Song , K. C. and Kang , Y. 2000 . Preparation of high surface area tin oxide powders by a homogeneous precipitation method . Mater. Lett. , 42 : 283 – 289 .
   Web of Science ®Google Scholar
• Porta , F. , Bifulco , C. , Fermo , P. , Bianchi , C. L. , Fadoni , M. and Prati , L. 1999 . Synthesis of spherical nanoparticles of Cu2L2O5 (L = Ho, Er) from w/o microemulsions . Colloid. Surface. A , 160 : 281 – 290 .
   Web of Science ®Google Scholar
• Agostiano , A. , Catalano , M. , Curri , M. L. , Della Monica , M. , Manna , L. and Vasanelli , L. 2000 . Synthesis and structural characterization of CdS nanoparticles prepared in a four‐components “water‐in‐oil” microemulsion . Micron. , 31 : 253 – 258 .
   PubMed Web of Science ®Google Scholar
• Xiangling , X. , Xuewu , G. , Qiang , Y. , Zhicheng , Z. , Ju , Z. , Aizhen , N. and Manwei , Z. 1999 . Growth of polymer nanoparticles in microemulsion polymerization initiated with x‐ray . Radiat. Phys. Chem. , 54 : 279 – 283 .
   Web of Science ®Google Scholar
• Tang , Z. , Liu , S. , Wang , Z. , Dong , S. and Wang , E. 2000 . Electrochemical synthesis of polyaniline nanoparticles . Electrochem. Commun. , 2 : 32 – 35 .
   Web of Science ®Google Scholar
• Fang , J. , Stokes , K. L. , Wiemann , J. and Zhou , W. 2000 . Nanocrystalline bismuth synthesized via an in situ polymerization microemulsion process . Mater. Lett. , 42 : 113 – 120 .
   Web of Science ®Google Scholar
• Capek , I. 1999 . Microemulsion polymerization of styrene in the presence of anionic emulsifier . Adv. Colloid Interfac. , 82 : 253 – 273 .
   Web of Science ®Google Scholar
• Meier , W. 1999 . Nanostructure synthesis using surfactants and copolymers . Curr. Opin. Colloid In. , 4 : 6 – 14 .
   Web of Science ®Google Scholar
• Oyewumi , M. O. and Mumper , R. J. 2002 . Gadolinium loaded nanoparticles engineered from microemulsion templates . Drug Dev. Ind. Pharm. , 28 : 317 – 328 .
   PubMed Web of Science ®Google Scholar
• Oyewumi , M. O. and Mumper , R. J. 2003 . Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate‐coated nanoparticles . Int. J. Pharm. , 251 : 85 – 97 .
   PubMed Web of Science ®Google Scholar
• Oyewumi , M. O. and Mumper , R. J. 2002 . Engineering tumor‐targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy . Bioconj. Chem. , 13 : 1328 – 1335 .
   PubMed Web of Science ®Google Scholar
• Cui , Z. and Mumper , R. J. 2002 . Plasmid DNA entrapped nanoparticles engineered from microemulsion precursors: in‐vitro and in‐vivo evaluation . Bioconj. Chem. , 13 : 1319 – 1327 .
   PubMed Web of Science ®Google Scholar
• Cui , Z. and Mumper , R. J. 2002 . Genetic immunization using nanoparticles engineered from microemulsion precursors . Pharm. Res. , 19 : 939 – 946 .
   PubMed Web of Science ®Google Scholar
• Cui , Z. and Mumper , R. J. 2002 . Topical immunization using nanoengineered genetic vaccines . J. Controlled Rel. , 81 : 173 – 184 .
   PubMed Web of Science ®Google Scholar
• Cui , Z. and Mumper , R. J. 2002 . Intranasal administration of plasmid DNA‐coated nanoparticles results in enhanced immune responses . J. Pharm. Pharmacol. , 54 : 1195 – 1203 .
   PubMed Web of Science ®Google Scholar
• Cui , Z. and Mumper , R. J. 2003 . The effect of co‐administration of adjuvants with a nanoparticle‐based genetic vaccine delivery system on the resulting immune responses . Eur. J. Pharm. Biopharm. , 55 : 11 – 18 .
   PubMed Web of Science ®Google Scholar
• Cui , Z. , Hsu , C. H. and Mumper , R. J. in press . Physical characterization and macrophage cell uptake of mannan‐coated nanoparticles . Drug Dev. Ind. Pharm. ,
   Web of Science ®Google Scholar
• Cui , Z. and Mumper , R. J. 2002 . Coating of cationized protein on engineered nanoparticles results in enhanced immune responses . Int. J. Pharm. , 238 : 229 – 239 .
   PubMed Web of Science ®Google Scholar
• Muller , R. H. , Mader , K. and Gohla , S. 2000 . Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art . Eur. J. Pharm. Biopharm. , 50 : 161 – 177 .
   PubMed Web of Science ®Google Scholar
• Mehnert , W. and Mader , K. 2001 . Solid lipid nanoparticles: production, characterization and applications . Adv. Drug Del. Rev. , 47 : 165 – 196 .
   PubMed Web of Science ®Google Scholar
• Dingler , A. and Gohla , S. 2002 . Production of solid lipid nanoparticles (SLN): scaling up feasibilities . J. Microencapsul. , 19 : 11 – 16 .
   PubMed Web of Science ®Google Scholar
• Marengo , E. , Cavalli , R. , Caputo , O. , Rodriguez , L. and Gasco , M. R. 2000 . Scale‐up of the preparation process of solid lipid nanospheres. Part I . Int. J. Pharm. , 205 : 3 – 13 .
   PubMed Web of Science ®Google Scholar
• Jenning , V. , Lippacher , A. and Gohla , S. H. 2002 . Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization . J. Microencapsul. , 19 : 1 – 10 .
   PubMed Web of Science ®Google Scholar
• Cavalli , R. , Caputo , O. , Carlotti , M. E. , Trotta , M. , Scarnecchia , C. and Gasco , M. R. 1997 . Sterilization and freeze‐drying of drug‐free and drug‐loaded solid lipid nanoparticles . Int. J. Pharm. , 148 : 47 – 54 .
   Web of Science ®Google Scholar
• Ugazio , E. , Cavalli , R. and Gasco , M. R. 2002 . Incorporation of cyclosporin A in solid lipid nanoparticles (SLN) . Int. J. Pharm. , 241 : 341 – 344 .
   PubMed Web of Science ®Google Scholar
• Oyewumi , M. and Mumper , R. J. Sterile and Freeze‐Dried Nanoparticles Engineered from Novel Microemulsion Templates . Proceedings of the American Association of Pharmaceutical Scientists Pharmaceutics and Drug Delivery Conference . Vol. 3050 , pp. 93 – 94 . Arlington , VA
   Google Scholar
• Liu , M. A. 1997 . The immunologist's grail: vaccines that generate cellular immunity . Proc. Natl. Acad. Sci. USA , 94 : 10496 – 10498 .
   PubMed Web of Science ®Google Scholar
• Wu , L. , Vandenabeele , S. and Georgopoulos , K. 2001 . Derivation of dendritic cells from myeloid and lymphoid precursors . Int. Rev. Immunol. , 20 ( 1 ) : 117 – 135 .
   PubMedGoogle Scholar
• Corr , M. , Lee , D. J. , Carson , D. A. and Tighe , H. 1996 . Gene vaccination with naked plasmid DNA: mechanism of CTL priming . J. Exp. Med. , 184 : 1555 – 1560 .
   PubMed Web of Science ®Google Scholar
• Corr , M. , von Damm , A. , Lee , D. J. and Tighe , H. 1999 . In vivo priming by DNA injection occurs predominantly by antigen transfer . J. Immunol. , 163 : 4721 – 4727 .
   PubMed Web of Science ®Google Scholar
• Doe , B. , Selby , M. , Barnett , S. , Baenziger , J. and Walker , C. M. 1996 . Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow‐derived cells . Proc. Natl. Acad. Sci. USA , 93 : 8578 – 8583 .
   PubMed Web of Science ®Google Scholar
• Steinman , R. M. , Pack , M. and Inaba , K. 1997 . Dendritic cells in the T‐cell areas of lymphoid organs . Immunol. Rev. , 156 : 25 – 37 .
   PubMed Web of Science ®Google Scholar
• Banchereau , J. and Steinman , R. M. 1998 . Dendritic cells and the control of immunity . Nature , 392 : 245 – 252 .
   PubMed Web of Science ®Google Scholar
• Jordens , R. , Thompson , A. , Amons , R. and Koning , F. 1999 . Human dendritic cells shed a functional, soluble form of the mannose receptor . Int. Immunol. , 11 : 1775 – 1780 .
   PubMed Web of Science ®Google Scholar
• Engering , A. J. , Cella , M. , Fluitsma , D. , Brockhaus , M. , Hoefsmit , E. C.M. , Lanzavecchia , A. and Pieters , J. 1997 . The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells . Eur. J. Immunol. , 27 : 2417 – 2425 .
   PubMed Web of Science ®Google Scholar
• Tan , M. C. , Mommaas , A. M. , Drijfhout , J. W. , Jordens , R. , Onderwater , J. J.M. , Verwoerd , D. , Mulder , A. A. , van der Heiden , A. N. , Scheideggar , D. , Oomen , L. C. , Ottenhoff , T. H.M. , Tulp , A. , Neefjes , J. J. and Koning , F. 1997 . Mannose receptor‐mediated uptake of antigens strongly enhances HLA class II‐restricted antigen presentation by cultured dendritic cells . Eur. J. Immunol. , 27 : 2426 – 2435 .
   PubMed Web of Science ®Google Scholar
• Gu , X. G. , Schmitt , M. , Hiasa , A. , Nagata , Y. , Ikeda , H. , Sasaki , Y. , Akiyoshi , K. , Sunamoto , J. , Nakamura , H. , Kuribayashi , K. and Shiku , H. 1998 . A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2‐expression murine sarcomas . Cancer Res. , 58 ( 15 ) : 3385 – 3390 .
   PubMed Web of Science ®Google Scholar
• McKenzie , I. F. , Apostolopoulos , V. , Lees , C. , Xing , P. X. , Lofthouse , S. , Osinski , C. , Popovski , V. , Acres , B. and Pietersz , G. 1998 . Oxidized mannan antigen conjugate preferentially stimulate T1 type immune responses . Vet. Immunol. Immunopathol. , 63 : 185 – 190 .
   PubMed Web of Science ®Google Scholar
• Lofthouse , S. A. , Apostolopoulos , V. , Pietersz , G. A. , Li , W. and McKenzie , I. F. 1997 . Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a Mucin‐1 tumour antigen . Vaccine. , 15 ( 14 ) : 1586 – 1593 .
   PubMed Web of Science ®Google Scholar
• Ohishi , K. , Kabeya , H. , Amanuma , H. and Onuma , M. 1997 . Peptide‐based bovine leukemia virus (BLV) vaccine that induces BLV‐Env specific Th‐1 type immunity . Leukemia , 3 : 223 – 226 .
   Google Scholar
• Kaneo , Y. , Tanaka , T. , Nakano , T. and Tamaguchi , Y. 2001 . Evidence for receptor‐mediated hepatic uptake of pullulan in rats . J. Control. Release , 70 : 365 – 373 .
   PubMed Web of Science ®Google Scholar
• Venkatesan , N. and Vyas , S. P. 2000 . Polysaccharide coated liposomes for oral immunization: development and characterization . Int. J. Pharm. , 203 : 169 – 177 .
   PubMed Web of Science ®Google Scholar
• Wang , L. , Ideda , H. , Ikuta , Y. , Schmitt , M. , Miyahara , Y. , Takahashi , Y. , Gu , X. , Nagata , Y. , Sasaki , Y. , Akiyoshi , K. , Sunamoto , J. , Nakamura , H. , Kuribayashi , K. and Shiku , H. 1999 . Bone marrow‐derived dendritic cells incorporate and process hydrophobized polysaccharide/oncoprotein complex as antigen presenting cells . Int. J. Oncol. , 14 : 695 – 701 .
   PubMed Web of Science ®Google Scholar
• Garber , M. E. and Jones , K. A. 1999 . HIV‐1 Tat: coping with negative elongation factors . Curr. Opin. Immunol. , 11 : 460 – 465 .
   PubMed Web of Science ®Google Scholar
• Ma , M. and Nath , A. 1997 . Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells . J. Virol. , 71 : 2495 – 2499 .
   PubMed Web of Science ®Google Scholar
• Re , M. C. , Furlini , G. , Vignoli , M. , Ramazzotti , E. , Roderigo , G. , De Rosa , V. , Zauli , G. , Lolli , S. , Capitani , S. and La Placa , M. 1995 . Effect of antibody to HIV‐1 Tat protein on viral replication in vitro and progression of HIV‐1 disease in vivo . J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. , 10 : 408 – 416 .
   PubMedGoogle Scholar
• Cafaro , A. , Caputo , A. , Fracasso , C. , Maggiorella , M. T. , Goletti , D. , Baroncelli , S. , Pace , M. , Sernicola , L. , Koanga‐Mogtomo , M. L. , Betti , M. , Borsetti , A. , Belli , R. , Akerblom , L. , Corrias , F. , Butto , S. , Heeney , J. , Verani , P. , Titti , F. and Ensoli , B. 1999 . Control of SHIV‐89.6P‐Infection of cynomolgus monkeys by HIV‐1 Tat protein vaccine . Nat. Med. , 5 : 643 – 650 .
   PubMed Web of Science ®Google Scholar
• Cafaro , A. , Titti , F. , Fracasso , C. , Maggiorella , M. T. , Baroncelli , S. , Caputo , A. , Goletti , D. , Borsetti , A. , Pace , M. , Fanales‐Belasio , E. , Ridolfi , B. , Negri , D. R. , Sernicola , L. , Belli , R. , Corrias , F. , Macchia , I. , Leone , P. , Michelini , Z. , ten Haaft , P. , Butto , S. , Verani , P. and Ensoli , B. 2001 . Vaccination with DNA containing Tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) . Vaccine. , 19 : 2862 – 2877 .
   PubMed Web of Science ®Google Scholar
• Shi , Z. , Curiel , D. T. and Tang , D. C. 1999 . DNA‐based non‐invasive vaccination onto the skin . Vaccine. , 17 ( 17 ) : 2136 – 2141 .
   PubMed Web of Science ®Google Scholar
• Fan , H. , Lin , Q. , Morrissey , G. R. and Khavari , P. A. 1999 . Immunization via hair follicles by topical application of naked DNA to normal skin . Nat. Biotechnol. , 17 ( 9 ) : 870 – 872 .
   PubMed Web of Science ®Google Scholar
• Tang , D. C. , Shi , Z. and Curiel , D. T. 1997 . Vaccination onto bare skin . Nature , 388 : 729 – 730 .
   PubMed Web of Science ®Google Scholar
• Cui , Z. and Mumper , R. J. 2001 . Chitosan‐based nanoparticles for topical genetic immunization . J. Controlled Rel. , 75 : 409 – 419 .
   PubMed Web of Science ®Google Scholar
• Cui , Z. , Fountain , W. , Clark , M. , Jay , M. and Mumper , R. J. 2003 . Novel ethanol‐in‐fluorocarbon microemulsions for topical genetic immunization . Pharm. Res. , 20 : 16 – 23 .
   PubMed Web of Science ®Google Scholar
• Pardridge , W. M. , Bickel , U. , Buciak , J. , Yang , J. and Diagne , A. 1994 . Enhanced endocytosis and anti‐human immunodeficiency virus type 1 activity of anti‐rev antibodies after cationization . J. Infect. Dis. , 169 : 55 – 61 .
   PubMed Web of Science ®Google Scholar
• Pardridge , W. M. , Bickel , U. , Buciak , J. , Yang , J. , Diagne , A. and Aepinus , C. 1994 . Cationization of a monoclonal antibody to the human immunodeficiency virus REV protein enhances cellular uptake but does not impair antigen binding of the antibody . Immunol. Lett. , 42 : 191 – 195 .
   PubMed Web of Science ®Google Scholar
• Muckerheide , A. , Apple , R. J. , Pesce , A. J. and Michael , J. G. 1987 . Cationization of protein antigens I. Alteration of immunogenic properties . J. Immunol. , 138 : 833 – 837 .
   PubMed Web of Science ®Google Scholar
• Jain , R. K. 1994 . Barriers to drug delivery in solid tumors . Sci. Am. , 271 : 58 – 65 .
   PubMed Web of Science ®Google Scholar
• Brown , J. M. and Giaccia , A. J. 1998 . The unique physiology of solid tumors: opportunities (and problems) for cancer therapy . Cancer Res. , 58 : 1408 – 1416 .
   PubMed Web of Science ®Google Scholar
• Jain , R. K. 1997 . Delivery of molecular and cellular medicine to solid tumors . Adv. Drug. Deliv. Rev. , 26 : 71 – 90 .
   PubMed Web of Science ®Google Scholar
• Wu , N. Z. , Da , D. , Rudoll , T. L. , Needham , D. , Whorton , A. R. and Dewhirst , M. W. 1993 . Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue . Cancer Res. , 53 : 3765 – 3770 .
   PubMed Web of Science ®Google Scholar
• Yuan , F. , Dellian , M. , Fukumura , D. , Leunig , M. , Berk , D. A. , Torchilin , V. P. and Jain , R. K. 1995 . Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size . Cancer Res. , 55 : 3752 – 3756 .
   PubMed Web of Science ®Google Scholar
• Hobbs , S. K. , Monsky , W. L. , Yuan , F. , Roberts , W. G. , Griffith , L. , Torchilin , V. P. and Jain , R. K. 1998 . Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment . Proc. Natl. Acad. Sci. USA , 95 : 4607 – 4612 .
   PubMed Web of Science ®Google Scholar
• Bally , M. B. , Masin , D. , Nayar , R. , Cullis , P. R. and Mayer , L. D. 1994 . Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor‐bearing mice . Cancer Chemother. Pharmacol. , 34 : 137 – 146 .
   PubMed Web of Science ®Google Scholar
• Nagayasu , A. , Uchiyama , K. and Kiwada , H. 1999 . The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs . Adv. Drug. Deliv. Rev. , 40 : 75 – 87 .
   PubMed Web of Science ®Google Scholar
• Vyas , S. P. , Singh , A. and Sihorkar , V. 2001 . Ligand‐receptor‐mediated drug delivery: an emerging paradigm in cellular drug targeting . Crit. Rev. Ther. Drug Carrier Syst. , 18 : 1 – 76 .
   PubMed Web of Science ®Google Scholar
• Thorpe , P. E. and Derbyshire , E. J. 1997 . Targeting the vasculature of solid tumors . J. Controlled Rel. , 48 : 277 – 288 .
   Web of Science ®Google Scholar
• Wang , S. and Low , P. S. 1998 . Folate‐mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells . J. Control. Release. , 53 : 39 – 48 .
   PubMed Web of Science ®Google Scholar
• Weitman , S. D. , Lark , R. H. , Coney , L. R. , Fort , D. W. , Frasca , V. , Zurawski , V. R. and Kamen , B. A. 1992 . Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues . Cancer Res. , 52 : 3396 – 3401 .
   PubMed Web of Science ®Google Scholar
• Kamen , B. A. and Caston , J. D. 1986 . Properties of a folate binding protein (FBP) isolated from porcine kidney . Biochem. Pharmacol. , 35 : 2323 – 2329 .
   PubMed Web of Science ®Google Scholar
• Lee , R. J. , Wang , S. and Low , P. S. 1996 . Measurement of endosome pH following folate receptor‐mediated endocytosis . Biochim. Biophys. Acta , 1312 : 237 – 242 .
   PubMed Web of Science ®Google Scholar
• Sudimack , J. and Lee , R. J. 2000 . Targeted drug delivery via the folate receptor . Adv. Drug Deliv. Rev. , 41 ( 2 ) : 147 – 162 .
   PubMed Web of Science ®Google Scholar
• Tokumitsu , H. , Hiratsuka , J. , Sakurai , Y. , Kobayashi , T. , Ichikawa , H. and Fukumori , Y. 2000 . Gadolinium neutron‐capture therapy using novel gadopentetic acid‐chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor . Cancer Lett. , 150 ( 2 ) : 177 – 182 .
   PubMed Web of Science ®Google Scholar
• Tokumitsu , H. , Ichikawa , H. and Fukumori , Y. 1999 . Chitosan‐gadopentetic acid complex nanoparticles for gadolinium neutron‐capture therapy of cancer: preparation by novel emulsion‐droplet coalescence technique and characterization . Pharm Res. , 16 ( 12 ) : 1830 – 1835 .
   PubMed Web of Science ®Google Scholar
• Miyamoto , M. , Hirano , K. , Ichikawa , H. , Fukumori , Y. , Akine , Y. and Tokuuye , K. 1999 . Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron‐capture therapy with tumor‐bearing hamsters . Biol. Pharm. Bull. , 22 ( 12 ) : 1331 – 1340 .
   PubMed Web of Science ®Google Scholar
• Jono , K. , Ichikawa , H. , Fujioka , K. , Fukumori , Y. , Akine , Y. and Tokuuye , K. 1999 . Preparation of lecithin microcapsules by a dilution method using the Wurster process for intraarterial administration in gadolinium neutron capture therapy . Chem. Pharm. Bull. , 47 ( 1 ) : 54 – 63 .
   PubMed Web of Science ®Google Scholar
• Watanabe , T. , Ichikawa , H. and and Fukumori , Y. 2002 . Tumor accumulation of gadolinium in lipid‐nanoparticles intravenously injected for neutron‐capture therapy of cancer . Eur. J. Pharm. Biopharm. , 54 : 119 – 124 .
   PubMed Web of Science ®Google Scholar